Eotaxin-2 and Colorectal Cancer: A Potential Target for Immune Therapy

Abstract

Taken together, these observations confirm eotaxin-2 as a chemokine strongly associated with primary and metastatic tumors of colorectal origin. Furthermore, the importance of this result may be a useful tool in the development of targeted therapeutic approaches to colorectal tumors.